GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype.
作者信息
Bahuau M, Pelet A, Vidaud D, Lamireau T, LeBail B, Munnich A, Vidaud M, Lyonnet S, Lacombe D
出版信息
J Med Genet. 2001 Sep;38(9):638-43. doi: 10.1136/jmg.38.9.638.
Abstract
摘要
相似文献
1
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype.
J Med Genet. 2001 Sep;38(9):638-43. doi: 10.1136/jmg.38.9.638.
2
Neurofibromatosis type 1: from genotype to phenotype.
J Med Genet. 2012 Aug;49(8):483-9. doi: 10.1136/jmedgenet-2012-100978.
3
4
GDNF is a chemoattractant for enteric neural cells.
Dev Biol. 2001 Jan 15;229(2):503-16. doi: 10.1006/dbio.2000.0100.
5
GDNF is required for kidney development and enteric innervation.
Cold Spring Harb Symp Quant Biol. 1996;61:445-57.
6
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy.
Clin Genet. 2000 Nov;58(5):341-4. doi: 10.1034/j.1399-0004.2000.580501.x.
7
The vasculopathy of NF1 and histogenesis control genes.
Clin Genet. 2000 Nov;58(5):345-7. doi: 10.1034/j.1399-0004.2000.580502.x.
8
Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).
Microsc Res Tech. 1999;45(4-5):292-302. doi: 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8.
9
Impaired dental cytodifferentiation in glial cell-line derived growth factor (GDNF) deficient mice.
Ann Anat. 2002 Jan;184(1):85-92. doi: 10.1016/S0940-9602(02)80041-3.
引用本文的文献
1
Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.
Cancers (Basel). 2020 Aug 26;12(9):2416. doi: 10.3390/cancers12092416.
2
Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.
PLoS Genet. 2014 Oct 16;10(10):e1004575. doi: 10.1371/journal.pgen.1004575. eCollection 2014 Oct.
3
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
BMC Med. 2013 Apr 23;11:109. doi: 10.1186/1741-7015-11-109.
4
The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
J Korean Med Sci. 2006 Feb;21(1):107-12. doi: 10.3346/jkms.2006.21.1.107.
Zotero 插件